当前位置:首页 - 行情中心 - 博瑞医药(688166) - 财务分析 - 现金流量表

博瑞医药

(688166)

  

流通市值:465.05亿  总市值:465.05亿
流通股本:4.23亿   总股本:4.23亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金275,672,789.11,010,560,886.9813,792,937.47573,592,287.65
  收到的税费返还26,337,116.3956,504,504.1648,813,455.7130,512,854.59
  收到其他与经营活动有关的现金15,897,264.3550,805,215.9641,416,883.9735,291,399.17
  经营活动现金流入小计317,907,169.841,117,870,607.02904,023,277.15639,396,541.41
  购买商品、接受劳务支付的现金58,550,490.52204,463,410.07286,207,185.98137,916,106.21
  支付给职工以及为职工支付的现金65,357,589.92265,530,091.9204,656,001.24146,885,915.99
  支付的各项税费23,387,168.2881,969,233.4667,140,777.5243,254,673.17
  支付其他与经营活动有关的现金63,618,928.61320,348,554.49226,429,610.38160,119,496.92
  经营活动现金流出小计210,914,177.33872,311,289.92784,433,575.12488,176,192.29
  经营活动产生的现金流量净额106,992,992.51245,559,317.1119,589,702.03151,220,349.12
二、投资活动产生的现金流量:
  收回投资收到的现金-110,170,515.3461,749,840.2151,170,515.34
  取得投资收益收到的现金-1,579,324.8733,041.280
  处置固定资产、无形资产和其他长期资产收回的现金净额6,160303,641.610-
  收到的其他与投资活动有关的现金-43,788,077.636,498,977.636,498,977.6
  投资活动现金流入小计6,160155,841,559.4298,281,859.0987,669,492.94
  购建固定资产、无形资产和其他长期资产支付的现金221,710,325.76257,199,197.47251,051,326.55191,654,193.43
  投资支付的现金5,593,449.23338,783,886.09272,103,670.16187,761,044.85
  支付其他与投资活动有关的现金--00
  投资活动现金流出小计227,303,774.99595,983,083.56523,154,996.71379,415,238.28
  投资活动产生的现金流量净额-227,297,614.99-440,141,524.14-424,873,137.62-291,745,745.34
三、筹资活动产生的现金流量:
  吸收投资收到的现金181,800,000103,000,00000
  其中:子公司吸收少数股东投资收到的现金181,800,000103,000,00000
  取得借款收到的现金316,351,900802,077,074.15595,962,819.75516,062,819.75
  收到其他与筹资活动有关的现金20,000,00021,000,000--
  筹资活动现金流入小计518,151,900926,077,074.15595,962,819.75516,062,819.75
  偿还债务支付的现金319,943,643.65786,710,467.93627,876,477.53338,143,192.67
  分配股利、利润或偿付利息支付的现金20,113,633.68135,734,274.41118,858,800.8843,755,874.18
  支付其他与筹资活动有关的现金8,703,637.2228,107,235.6722,994,592.3118,470,313.4
  筹资活动现金流出小计348,760,914.55950,551,978.01769,729,870.72400,369,380.25
  筹资活动产生的现金流量净额169,390,985.45-24,474,903.86-173,767,050.97115,693,439.5
四、汇率变动对现金及现金等价物的影响3,123,026.272,118,247.621,333,672.341,913,878.09
五、现金及现金等价物净增加额52,209,389.24-216,938,863.28-477,716,814.22-22,918,078.63
  加:期初现金及现金等价物余额754,101,930.95971,040,794.23971,040,794.23971,040,794.23
  期末现金及现金等价物余额806,311,320.19754,101,930.95493,323,980.01948,122,715.6
补充资料:
  净利润-141,263,284.54-82,226,988.64
  资产减值准备-19,942,512.38-5,233,377.22
  固定资产和投资性房地产折旧-91,406,078.94-40,931,247.07
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-91,406,078.94-40,931,247.07
  无形资产摊销-5,877,357.74-2,857,548.66
  长期待摊费用摊销-9,187,226.6-4,722,790.4
  处置固定资产、无形资产和其他长期资产的损失-0-0
  固定资产报废损失-148,435.21-7,983.31
  公允价值变动损失-5,699,782.83-1,564,027.29
  财务费用-50,515,554.66-25,742,683.74
  投资损失-11,633,803.45-6,584,076.76
  递延所得税--31,266,124.51--13,211,757.25
  其中:递延所得税资产减少--31,266,124.51--13,211,757.25
    递延所得税负债增加-0-0
  存货的减少--35,549,548.22-9,124,499.89
  经营性应收项目的减少--149,927,051.69--55,506,849.29
  经营性应付项目的增加-84,399,593.34-8,392,793.26
  其他-0-0
  债务转为资本-0-0
  一年内到期的可转换公司债券-0-0
  融资租入固定资产-0-0
  现金的期末余额-754,101,930.95-948,122,715.6
  减:现金的期初余额-971,040,794.23-971,040,794.23
  加:现金等价物的期末余额-0-0
  减:现金等价物的期初余额-0-0
  现金及现金等价物的净增加额--216,938,863.28--22,918,078.63
公告日期2025-04-182025-04-032024-10-302024-08-24
审计意见(境内)标准无保留意见
TOP↑